Clinical Trial Update: Exhaled Breath Condensate as a Measure of Airway Inflammation in Children With Asthma

View source ↗

Summary

A clinical trial evaluating exhaled breath condensate as a biomarker of airway inflammation in children with asthma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Asthma | Status: COMPLETED